Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

BACKGROUND: Limited data is available to guide the choice of the conditioning regimen for patients with acute myeloid leukemia (AML) undergoing transplant with persistent disease. METHODS: We retrospectively compared outcome of fludarabine-treosulfan (FT), thiotepa-busulfan-fludarabine (TBF), and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceni, Francesco, Labopin, Myriam, Brecht, Arne, Kröger, Nicolaus, Eder, Matthias, Tischer, Johanna, Labussière-Wallet, Hélène, Einsele, Hermann, Beelen, Dietrich, Bunjes, Donald, Niederwieser, Dietger, Bochtler, Tilmann, Savani, Bipin N., Mohty, Mohamad, Nagler, Arnon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482556/
https://www.ncbi.nlm.nih.gov/pubmed/31023346
http://dx.doi.org/10.1186/s13045-019-0727-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482556/
https://www.ncbi.nlm.nih.gov/pubmed/31023346
http://dx.doi.org/10.1186/s13045-019-0727-4

Ejemplares similares